Navigation Links
Retinal Vein Occlusion Therapeutics - Pipeline Assessment and Market Forecasts to 2019
Date:8/6/2012

Therapeutics Market, Germany, Revenue ($m), 2006- 2011 29

Table 12: Retinal Vein Occlusion Therapeutics Market, Germany, Forecasts ($m), 2011- 2019 30

Table 13: Retinal Vein Occlusion Therapeutics Market, Italy, Revenue ($m), 2006- 2011 31

Table 14: Retinal Vein Occlusion Therapeutics Market, Italy, Forecasts ($m), 2011- 2019 32

Table 15: Retinal Vein Occlusion Therapeutics Market, Spain, Revenue ($m), 2006- 2011 33

Table 16: Retinal Vein Occlusion Therapeutics Market, Spain, Forecasts ($m), 2011- 2019 34

Table 17: Retinal Vein Occlusion Therapeutics Market, The UK, Revenue ($m), 2006- 2011 35

Table 18: Retinal Vein Occlusion Therapeutics Market, The UK, Forecasts ($m), 2011- 2019 36

Table 19: Retinal Vein Occlusion Therapeutics Market, Japan, Revenue ($m), 2006- 2011 37

Table 20: Retinal Vein Occlusion Therapeutics Market, Japan, Forecasts ($m), 2011- 2019 38

Table 21: Lucentis Phase III Clinical Trial Details 43

Table 22: Number (%) of Patients With ? 15 Letter Improvement from Baseline in Best-Corrected Visual Acuity 44

Table 23: Adverse Reactions Reported by >2% of Patients in the First Six Months 44

Table 24: Retinal Vein Occlusion Therapeutics, Phase III Pipeline, 2012 47

Table 25: Retinal Vein Occlusion Therapeutics, Phase II/III Pipeline, 2012 47

Table 26: Retinal Vein Occlusion Therapeutics, Phase II Pipeline, 2012 48

Table 27: Retinal Vein Occlusion Therapeutics, Phase I/II Pipeline, 2012 48

Table 28: RVO Therapeutics - Most Promising Drugs Under Clinical Development, 2012 51

Table 29: Eylea Phase III Clinical Trial Details 53

Table 30: Retinal Vein Occlusion Therapeutics, Clinical Trials by Country, 2012 54

Table 31: Retinal Vein Occlusion Therapeutics, Clinical Trials by Phase, 2012 55

Table 32: Retinal Vein Occlusion Therapeutics, Clinical Trials by Status, 2012 56

Table 33: Retinal Vein Occlusion
'/>"/>

SOURCE Reportlinker
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Frost & Sullivan: High Uptake of New Drug Therapies and Aging Population Expansion Keep the U.S. Retinal Therapeutics Market Buoyant
2. Cell Therapeutics, Inc. (CTI) to Report First Quarter Financial Results on April 20
3. Faruqi & Faruqi, LLP Encourages Investors Who Suffered Substantial Losses Investing in Chelsea Therapeutics International, Ltd. to Contact the Firm
4. Argos Therapeutics Secures $25 million Series D Financing to Commence Phase 3 ADAPT Study in Patients with Metastatic Renal Cell Carcinoma (mRCC) in Mid-2012
5. Novelos Therapeutics Announces Successful Completion of First Cohort In Lung Cancer Trial With I-124-CLR1404 (LIGHT) Cancer-Targeted PET Imaging Agent at UW Carbone Cancer Center
6. Zacks Industry Outlook Highlights: Eli Lilly, Forest Labs, ViroPharma, Novartis and United Therapeutics
7. Oxford BioTherapeutics Appoints Senior Industry Leader to Head its New Clinical Development Operations in Basel, Switzerland
8. Nektar Therapeutics Reports Financial Results for the First Quarter of 2012
9. Cara Therapeutics Licenses Novel Kappa Opioid Agonist, CR845, to Chong Kun Dang Pharmaceutical Corporation For South Korean Market
10. Zenobia Therapeutics, Inc. And BioBlocks, Inc. Announce Sale Of A Joint Fragment Library Ideal For Screening By All Popular Methods
11. New Forecast Shows Global Protein Therapeutics Market to Reach $143.4 Billion by 2015
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2015)... 23, 2015  CytoSorbents Corporation (NASDAQ CM: CTSO), a ... cytokine adsorber to reduce deadly inflammation in critically-ill ... $385,642, net of transaction costs, in non-dilutive funding ... Tax Certificate Transfer Program sponsored by the New ...
(Date:1/23/2015)... Jan. 23, 2015 Gem Pharmaceuticals announced today that ... enrolled into the Company,s Phase 2 clinical trial.  This ... Gem,s lead compound, GPX-150 (an investigational medication), in approximately ... disease. Logo - http://photos.prnewswire.com/prnh/20150123/170966LOGO ...
(Date:1/23/2015)... 23, 2015 Tianyin Pharmaceutical Inc. (NYSE Amex: ... the development and sale of patented biopharmaceutical medicine, modernized ... ingredients (API) today announced the business and development progress ... 1. Following the September 2014 JCM application (No. ...
Breaking Medicine Technology:CytoSorbents Receives $385,000 in Non-Dilutive Funding from the New Jersey Technology Business Tax Certificate Transfer Program 2CytoSorbents Receives $385,000 in Non-Dilutive Funding from the New Jersey Technology Business Tax Certificate Transfer Program 3Gem Pharmaceuticals Announces Enrollment of Initial Patients in its Phase 2 Clinical Trial to Assess the Efficacy and Safety of GPX-150 in Sarcoma Patients 2TPI's JCM Updates on Import Registration for International Clients 2TPI's JCM Updates on Import Registration for International Clients 3TPI's JCM Updates on Import Registration for International Clients 4
... Confirms Role of AMBIEN CR in Effectively Managing Insomnia to ... Improve Quantity and Quality of Work Performance, BRIDGEWATER, ... study that showed patients with chronic,insomnia who were treated with ... experienced significant improvements in two,key parameters of work performance - ...
... - favorable pharmacokinetic and safety data observed in first ... trial of novel Fleximer(TM) anticancer ... a cancer,therapeutics company, announced interim results of a Phase ... with advanced solid tumors.,The data was presented by Edward ...
Cached Medicine Technology:New Data Show Improvements in Work Performance in Patients with Chronic Insomnia Treated with AMBIEN CR(R) (zolpidem tartrate extended-release) Tablets CIV 2New Data Show Improvements in Work Performance in Patients with Chronic Insomnia Treated with AMBIEN CR(R) (zolpidem tartrate extended-release) Tablets CIV 3New Data Show Improvements in Work Performance in Patients with Chronic Insomnia Treated with AMBIEN CR(R) (zolpidem tartrate extended-release) Tablets CIV 4Mersana Therapeutics Reports Phase I Results for XMT-1001 in Patients with Solid Tumors at AACR-NCI-EORTC International Conference 2Mersana Therapeutics Reports Phase I Results for XMT-1001 in Patients with Solid Tumors at AACR-NCI-EORTC International Conference 3
(Date:1/22/2015)... 22, 2015 Gabe’s Chemo Duck Program is pleased ... first app ever created for kids with cancer. The Chemo Duck ... devices, is filled with enjoyable games to help children of all ... free app helps to keep kids entertained, educated and at ease ...
(Date:1/22/2015)... 2015 Angelweddingdress is a famous wedding dress ... customers to follow it on Facebook, Twitter, and Pinterest. The ... gift. Angelweddingdress draws a lottery every week. , Moreover, the ... 28, 2015. Click Angelweddingdress homepage for more information. ...
(Date:1/22/2015)... Juvent Sports ( http://www.juventsports.com ) and David Leadbetter ... to bestow a Juvent Sports Achievement award upon an ... The award commemorated and congratulated McKitrick for her record ... her first amateur tournament in 1979 and most recently ...
(Date:1/22/2015)... For over 20 years, Dr. David Cruz of Cruz Chiropractic ... treated just about every type of injury that can result from ... same twenty-plus years, the team at Doctors on Liens ... possible doctor. With the combined breadth of experience between ...
(Date:1/22/2015)... La Jolla, Calif. (PRWEB) January 22, 2015 ... and Assemblymembers Susan Bonilla (D-Concord) and Kristin Olsen ... (CHI) for their leadership in advancing biotechnology, biomedical ... Mitchell, Bonilla and Olsen each received the “2014 ...
Breaking Medicine News(10 mins):Health News:Chemo Duck Launches First App Ever Created for Kids with Cancer 2Health News:Chemo Duck Launches First App Ever Created for Kids with Cancer 3Health News:Angelweddingdress Invites Its Customers To Follow It On Facebook, Twitter, And Pinterest 2Health News:All-Time Leading Female Amateur Golfer Arlene McKitrick Receives Juvent Sports Achievement Award at 2015 PGA Show 2Health News:All-Time Leading Female Amateur Golfer Arlene McKitrick Receives Juvent Sports Achievement Award at 2015 PGA Show 3Health News:Industry Leading Chiropractor in Oceanside Joins the Doctors on Liens Network 2Health News:California Biomedical Community Honors Senator Holly Mitchell, Assemblymembers Susan Bonilla & Kristin Olsen 2Health News:California Biomedical Community Honors Senator Holly Mitchell, Assemblymembers Susan Bonilla & Kristin Olsen 3
... heart failure rarely occurs among leukemia patients who take ... Anderson Cancer Center found after an exhaustive review of ... in clinical trials for the drug. , Researchers found ... have been caused by heart failure. Of those, 18 ...
... edition of The Journal of Immunology provide key new ... a principal investigator in SBRIs Viral Vaccines Program who ... Medical Center, is senior author on one of three ... symptom of AIDS, is likely a part of a ...
... Universal,Health Realty Income Trust (NYSE: UHT ) ... pay a quarterly dividend of $.575 per share ... of September 17, 2007. Universal Health Realty ... healthcare and human service related facilities including acute,care ...
... 6 ABQAURP is pleased to announce the,2007-08 ... Medical,Errors." The core content includes patient safety initiatives, ... populations,responsibility for error reporting and public education. ... -- serious and,costly errors in the provision of ...
... An Evening with Tim McGraw and Friends, ... Presented by Anheuser-Busch Companies, NAPA, Calif., ... annual fundraising gala on Friday, Nov. 2 at Grant,s Farm,the ... Anheuser-Busch,Companies is sponsoring "Denim & Diamonds: An Evening with Tim ...
... - MaxLife Fund Corp. (OTC:,MXFD), is pleased to announce ... Settlement Policies with a total face value of $4,000,000. ... Settlement,Policies and Portfolios that are available to be purchased. ... the company to profit,and create value for our shareholders. ...
Cached Medicine News:Health News:Study finds heart failure is rare among leukemia patients on imatinib 2Health News:Study finds heart failure is rare among leukemia patients on imatinib 3Health News:SIV infection of natural hosts provides new insights into HIV disease complexity 2Health News:ABQAURP Announces Certificate Course in Medical Error Prevention 2Health News:The Tug McGraw Foundation Announces 2007 Fundraising Gala 2Health News:The Tug McGraw Foundation Announces 2007 Fundraising Gala 3Health News:The Tug McGraw Foundation Announces 2007 Fundraising Gala 4
...
...
...
... Anterior Cervical Plate System allows for ... along slots in the plate, while ... end of the construct. In addition, ... pre-compression features that enable the surgeon ...
Medicine Products: